Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 348

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study

Open access
Araki, Tetsuro, Putman, Rachel K., Hatabu, Hiroto, Gao, Wei, Dupuis, Josée, Latourelle, Jeanne C., Nishino, Mizuki, Zazueta, Oscar E., Kurugol, Sila, Ross, James C., San José Estépar, Raúl, Schwartz, David A., Rosas, Ivan O., Washko, George R., O’Connor, George T., Hunninghake, Gary M. · 2016 · American Journal of Respiratory and Critical Care Medicine

Abstract

RATIONALE: The relationship between the development and/or progression of interstitial lung abnormalities (ILA) and clinical outcomes has not been previously investigated. OBJECTIVES: To determine the risk factors for, and the clinical consequences of, having ILA progression in participants from the Framingham Heart Study. METHODS: ILA were assessed in 1,867 participants who had serial chest computed tomography (CT) scans approximately 6 years apart. Mixed effect regression (and Cox) models were used to assess the association between ILA progression and pulmonary function decline (and mortality). MEASUREMENTS AND MAIN RESULTS: During the follow-up period 660 (35%) participants did not have ILA on either CT scan, 37 (2%) had stable to improving ILA, and 118 (6%) had ILA with progression (the remaining participants without ILA were noted to be indeterminate on at least one CT scan). Increasing age and increasing copies of the MUC5B promoter polymorphism were associated with ILA progression. After adjustment for covariates, ILA progression was associated with a greater FVC decline when compared with participants without ILA (20 ml; SE, ±6 ml; P = 0.0005) and with those with ILA without progression (25 ml; SE, ±11 ml; P = 0.03). Over a median follow-up time of approximately 4 years, after adjustment, ILA progression was associated with an increase in the risk of death (hazard ratio, 3.9; 95% confidence interval, 1.3-10.9; P = 0.01) when compared with those without ILA. CONCLUSIONS: These findings demonstrate that ILA progression in the Framingham Heart Study is associated with an increased rate of pulmonary function decline and increased risk of death.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201512-2523oc

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 348

Metadata

Authors
Araki, T., Putman, R. K., Hatabu, H., Gao, W., Dupuis, J., Latourelle, J. C., Nishino, M., Zazueta, O. E., Kurugol, S., Ross, J. C., San José Estépar, R., Schwartz, D. A., Rosas, I. O., Washko, G. R., O’Connor, G. T., & Hunninghake, G. M.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2016-12-15
Volume
194
Issue
12
Pages
1514-1522
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2424800769
Cited by
348
References
25
FWCI
23.30
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study. https://app.cochat.ai/papers/10.1164/rccm.201512-2523oc
The paper
Araki, T., Putman, R. K., Hatabu, H., Gao, W., Dupuis, J., Latourelle, J. C., Nishino, M., Zazueta, O. E., Kurugol, S., Ross, J. C., San José Estépar, R., Schwartz, D. A., Rosas, I. O., Washko, G. R., O’Connor, G. T., & Hunninghake, G. M. (2016). Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201512-2523oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.